Upgrade to SI Premium - Free Trial

Biogen (BIIB) Surges 18.5% Pre-Market After Announcing Plans to Pursue Regulatory Approval for Aducanumab in Alzheimer’s Disease

October 22, 2019 6:41 AM
Biogen (NASDAQ: BIIB) Surges ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Trader Talk

Next Articles